Gold nanoparticles for sustained antileukemia drug release: development, optimization and evaluation by quality-by-design approach.

Adena SKR, Upadhyay M, Vardhan H, Mishra B

DOI: 10.2217/nnm-2018-0306
Published: 2019 Apr
Container: Nanomedicine (London, England)
Publisher: Not recorded
Open access: unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2217/nnm-2018-0306,
  title = {Gold nanoparticles for sustained antileukemia drug release: development, optimization and evaluation by quality-by-design approach.},
  author = {Adena SKR and Upadhyay M and Vardhan H and Mishra B},
  year = {2019},
  journal = {Nanomedicine (London, England)},
  doi = {10.2217/nnm-2018-0306},
  url = {https://doi.org/10.2217/nnm-2018-0306}
}

RIS

TY  - JOUR
TI  - Gold nanoparticles for sustained antileukemia drug release: development, optimization and evaluation by quality-by-design approach.
AU  - Adena SKR
AU  - Upadhyay M
AU  - Vardhan H
AU  - Mishra B
PY  - 2019
JO  - Nanomedicine (London, England)
DO  - 10.2217/nnm-2018-0306
UR  - https://doi.org/10.2217/nnm-2018-0306
ER  -

APA

SKR, A., M, U., H, V., & B, M. (2019). Gold nanoparticles for sustained antileukemia drug release: development, optimization and evaluation by quality-by-design approach.. Nanomedicine (London, England). https://doi.org/10.2217/nnm-2018-0306

Source records

pubmed · retrieved 2026-09-25T05:27:18.136Z